StockData
Nkarta, Inc. logo

Nkarta, Inc. (NKTX) stock

NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30
$1.15−0.10 (-8.00%)

Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%

Nkarta revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nkarta's revenue for the twelve months ending Dec 31, 2019 was $115.00K. For fiscal 2025 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2019Dec 31, 2019$115.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$0–
Q2 FY2019Jun 30, 2019$2.31K–

More Nkarta figures

See a number that looks wrong?